期刊文献+

雷贝拉唑三联疗法治疗十二指肠溃疡60例 被引量:7

原文传递
导出
摘要 [目的]观察雷贝拉唑、阿莫西林、替硝唑三联疗法治疗十二指肠溃疡(DU)的疗效。[方法]将120例幽门螺杆菌(Hp)阳性的DU患者随机分为2组,各60例,治疗组,采用雷贝拉唑三联疗法治疗,对照组采用奥美拉唑三联疗法治疗,2组患者均服药4周,并在停药4周后复查胃镜及Hp,比较2组溃疡愈合率及Hp根除率。[结果]治疗组溃疡愈合率88.33%,对照组85.00%,2组比较差异无统计学意义(P>0.05);治疗组Hp根除率91.67%,对照组78.33%,2组比较差异有统计学意义(P<0.05)。[结论]雷贝拉唑三联疗法根除Hp治疗DU优于奥美拉唑三联疗法。
作者 周红军
出处 《中国中西医结合消化杂志》 CAS 2011年第2期117-118,共2页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
  • 相关文献

参考文献3

二级参考文献21

  • 1张燕捷,吴叔明.幽门螺杆菌耐药性的研究现状[J].上海第二医科大学学报,2005,25(1):93-96. 被引量:19
  • 2钟英强,郭佳念,许哲,颜蓉,李惠君,曾志勇.以雷贝拉唑与加替沙星为基础的三联疗法作为幽门螺杆菌感染根除失败的补救方案的研究[J].中国新药杂志,2007,16(13):1046-1049. 被引量:7
  • 3[1]Wong BC, Wong WM, Yee YK, et al.Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection[J].Aliment Pharmacol Ther,2001,15(12):1959-1965.
  • 4[3]Nagahara A, Miwa H,Ogawa K,et al.Assition of Metronidazole to Rabeprazole-Amoxicillin-Clllarithromycin Regimen for Helicobacter pylori infection Provides an Excellent Cure Rate with Five-Day therapy[J]. Helicobacter,2000,5(2):88-93.
  • 5[4]Treiber G,Ammon S.Amoxicillin,metronidazole,omeprazole,clarithromycin:a new,short quadruple therapy for Helicobacter pylori eradication[J].Helicobacter.1998,3(1):54-58.
  • 6[5]Richardson P,Hawkey CJ,Stack WA.Proton pump inhititors:Pharmacology and rationale for use in gastrointestinal disorders[J].Drugs,1998,56(3):307-335.(Review)
  • 7[6]Sachs G,Shin JM, Briving C,et al. The pharmacology of the gastric acid pump:the H+,K+ATPase [J].Annu Rev Pharmacol Toxicol,1995,35:277-305.(Review)
  • 8[7]Kawakami Y,Akahane T, Yamaguchi M, et al.In vitro activities of rabeprazole,a novel proton pump inhibitor and its thioether derivative alone and combination with other antimicobials against recent clinical isolates of Helicobacter pylori [J].Antimicrob Agents Chemother ,2000,44(2):458-461.
  • 9[8]Stone GG, Shortridge D, Flamm RK, et al. Identification of a 23S rRNA gene mutation in clarithromycin-resistance Helicobacter pylori[J]. Helicobacter,1996,1(4):227-228.
  • 10[9]Versalovic J, Shortridge D, Kibler K, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori[J]. Antimicrob Agents Chemother,1996,40(2):477-480.

共引文献20

同被引文献78

引证文献7

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部